title: Does more intensive treatment cure more patients with acute myeloid leukemia? The BGMT Group.
authors.affiliation: Department of Hematology, Bordeaux, France.
authors.forename: J
authors.initials: J
authors.lastname: Reiffers
authors.forename: D
authors.initials: D
authors.lastname: Maraninchi
authors.forename: F
authors.initials: F
authors.lastname: Rigal-Huguet
authors.forename: M
authors.initials: M
authors.lastname: Michallet
authors.forename: G
authors.initials: G
authors.lastname: Marit
authors.forename: A M
authors.initials: AM
authors.lastname: Stoppa
authors.forename: M
authors.initials: M
authors.lastname: Attal
authors.forename: D
authors.initials: D
authors.lastname: Hollard
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D017024:Chemotherapy, Adjuvant; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000601:surgery; D012074:Remission Induction